Alpha Growth plc
("Alpha" or the "Company")
Director / PDMR Dealing
Alpha Growth Plc (LSE: ALGW and OTCQB: ALPGF), a leading financial services company in the life insurance linked asset/wealth management business, is pleased to announce that the Company has been notified that the Directors of the Company named below have purchased ordinary shares of 0.1p each in the Company ("Shares") as listed below. The resulting interests of each of the Directors named below in the ordinary shares of the Company are also listed below.
| Name | Shares in Alpha before purchase | Shares in Alpha purchased | Resulting number of Shares held | % of total shares in issue |
| Gobind Sahney | 7,045,834 | 7,169,791 | 14,215,625 | 3.04 |
| Jason Sutherland | 3,398,639 | 7,169,791 | 10,568,430 | 2.26 |
Notification and public disclosure of transactions by persons discharging managerial responsibilities.
| 1. | Details of the person discharging managerial responsibilities/person closely associated | |||||||
| a) | Name: | Gobind Sahney | ||||||
| 2. | Reason for the notification | |||||||
| a) | Position/status: | Executive Chairman & Chief Executive Officer | ||||||
| b) | Initial notification/Amendment: | Initial notification | ||||||
| 3. | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |||||||
| a) | Name: | Alpha Growth plc | ||||||
| b) | LEI: | 213800T46KFT32KYKR91 | ||||||
| 4. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |||||||
| a) | Description of the financial instrument, type of instrument: Ordinary 0.1p Identification code: GB00BYWKBC49
|
| ||||||
| b) | Nature of the transaction: | Purchase | ||||||
| c) | Price(s) and volume(s): |
| ||||||
| d) | Aggregated information: Aggregated volume: Price: | Single transaction as in 4 c) above
| ||||||
| e) | Date of the transaction: | 2025-03-31 | ||||||
| f) | Place of the transaction: | London Stock Exchange | ||||||
| 1. | Details of the person discharging managerial responsibilities/person closely associated | |||||||
| a) | Name: | Jason Sutherland | ||||||
| 2. | Reason for the notification | |||||||
| a) | Position/status: | Executive Director & Chief Operating Officer | ||||||
| b) | Initial notification/Amendment: | Initial notification | ||||||
| 3. | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |||||||
| a) | Name: | Alpha Growth plc | ||||||
| b) | LEI: | 213800T46KFT32KYKR91 | ||||||
| 4. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |||||||
| a) | Description of the financial instrument, type of instrument: Ordinary 0.1p Identification code: GB00BYWKBC49
|
| ||||||
| b) | Nature of the transaction: | Purchase | ||||||
| c) | Price(s) and volume(s): |
| ||||||
| d) | Aggregated information: Aggregated volume: Price: | Single transaction as in 4 c) above
| ||||||
| e) | Date of the transaction: | 2025-03-31 | ||||||
| f) | Place of the transaction: | London Stock Exchange | ||||||
| Alpha Growth plc | +44 (0) 20 3959 8600 |
| Gobind Sahney, Executive Chairman | |
|
Allenby Capital Limited | +44 (0) 20 3328 5656 |
| Amrit Nahal (Sales and Corporate Broking) | |
| Nick Athanas / Piers Shimwell (Corporate Finance) | |
|
UK Investor Relations - Mark Treharne |
About Alpha Growth plc
Specialist in Longevity Assets
Alpha Growth plc is a financial advisory business providing specialist consultancy, advisory, and supplementary services to institutional and qualified investors globally in the multi-billion dollar market of longevity assets and insurance linked asset and wealth management. Building on its well-established network, the Alpha Growth group has a unique position in the insurance and asset services and investment business, as a listed entity with global reach. The group's strategy is to expand its advisory and business services via acquisitions and joint ventures in the UK and the US to attain commercial scale and provide holistic solutions to alternative institutional investors who are in need of specialised skills and unique access to deploy their financial resource in longevity assets.
Longevity Assets and Non-correlation
As a longevity asset, it is non-correlated to the real estate, equity capital and commodity markets. Its value is a function of time because as time passes the value gets closer to the face value of the policy. Hence creating a steady increase in the net asset value of the investment. This makes it highly attractive to investors wishing to counteract volatility within an investment portfolio and add yield.
Note: The Company only advises on and manages Longevity Assets that originate in the USA where the structured and life settlement market is highly regulated.
***END***
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.